- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- monomer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x ZN: ZINC ION(Non-covalent)
ZN.4: 5 residues within 4Å:- Chain A: D.136, T.174, D.323, H.324
- Ligands: NKR.9
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.136, A:D.136, A:T.174, A:D.323, A:H.324
ZN.5: 4 residues within 4Å:- Chain A: D.276, H.280, H.439
- Ligands: NKR.9
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:D.276, A:D.276, A:H.280, A:H.439
- 1 x CA: CALCIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x K: POTASSIUM ION(Non-covalent)
- 2 x NKR: (2R)-2-hydroxy-3-(phosphonooxy)propyl (4Z,7E,10E,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate(Non-covalent)
NKR.9: 19 residues within 4Å:- Chain A: I.132, S.134, K.173, T.174, F.175, L.178, A.182, N.195, L.208, W.219, W.225, F.238, A.269, Y.271, D.276, H.280, H.439
- Ligands: ZN.4, ZN.5
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:I.132, A:A.182, A:W.219, A:W.225, A:W.225, A:A.269, A:Y.271, A:Y.271, A:Y.271
- Hydrogen bonds: A:T.174, A:N.195
- Water bridges: A:K.173
- Salt bridges: A:H.280, A:H.439
NKR.10: 9 residues within 4Å:- Chain A: Y.179, F.214, H.216, R.217, W.219, G.220, P.223, W.225
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.2
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.214, A:H.216, A:W.219, A:W.219, A:P.223, A:W.225
- 2 x SCN: THIOCYANATE ION(Non-functional Binders)
SCN.11: 7 residues within 4Å:- Chain A: P.171, K.173, G.194, N.195, S.196, V.350, R.356
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.195, A:S.196, A:R.356
- Water bridges: A:K.173
SCN.12: 5 residues within 4Å:- Chain A: S.196, M.197, Y.198, V.350, R.358
No protein-ligand interaction detected (PLIP)- 21 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.13: 7 residues within 4Å:- Chain A: P.509, R.788, E.791, D.797, Y.806, L.810, K.813
Ligand excluded by PLIPEDO.14: 8 residues within 4Å:- Chain A: E.115, I.116, C.159, G.160, Y.455, G.456, K.460, Y.461
Ligand excluded by PLIPEDO.15: 8 residues within 4Å:- Chain A: G.639, F.640, P.643, P.644, Y.645, K.670, W.673, Q.677
Ligand excluded by PLIPEDO.16: 5 residues within 4Å:- Chain A: Y.566, F.586, F.699, R.707, D.708
Ligand excluded by PLIPEDO.17: 3 residues within 4Å:- Chain A: R.157, H.162, K.464
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain A: Y.666, Y.701, Q.715, V.724, P.725, T.726, H.758
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain A: K.386, L.411, V.412, E.413
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain A: Q.391, H.392, T.726, H.727, H.758, R.759
Ligand excluded by PLIPEDO.21: 4 residues within 4Å:- Chain A: P.485, A.486, P.487, N.488
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain A: I.585, F.586, E.710, Y.716, S.721, P.723
Ligand excluded by PLIPEDO.23: 6 residues within 4Å:- Chain A: L.736, L.749, S.750, V.751, L.812, Y.815
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain A: L.565, R.707, G.795
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain A: N.339, K.379, K.380
Ligand excluded by PLIPEDO.26: 7 residues within 4Å:- Chain A: H.246, F.270, S.272, Q.274, E.295, I.296, T.299
Ligand excluded by PLIPEDO.27: 3 residues within 4Å:- Chain A: R.561, R.800, K.801
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain A: P.667, A.668, R.671, P.760
Ligand excluded by PLIPEDO.29: 5 residues within 4Å:- Chain A: P.748, L.749, R.804, E.808, L.812
Ligand excluded by PLIPEDO.30: 3 residues within 4Å:- Chain A: K.460, Y.461, R.500
Ligand excluded by PLIPEDO.31: 8 residues within 4Å:- Chain A: F.669, V.672, P.757, H.758, R.759, D.761, N.762, L.779
Ligand excluded by PLIPEDO.32: 6 residues within 4Å:- Chain A: K.386, E.764, S.765, E.778, L.779, M.782
Ligand excluded by PLIPEDO.33: 6 residues within 4Å:- Chain A: G.191, N.402, R.403, R.404
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.2, NAG-NAG-BMA-MAN-MAN-MAN.2
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nishimasu, H. et al., Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat.Struct.Mol.Biol. (2011)
- Release Date
- 2011-01-19
- Peptides
- Ectonucleotide pyrophosphatase/phosphodiesterase family member 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- monomer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x ZN: ZINC ION(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x K: POTASSIUM ION(Non-covalent)
- 2 x NKR: (2R)-2-hydroxy-3-(phosphonooxy)propyl (4Z,7E,10E,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate(Non-covalent)
- 2 x SCN: THIOCYANATE ION(Non-functional Binders)
- 21 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nishimasu, H. et al., Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat.Struct.Mol.Biol. (2011)
- Release Date
- 2011-01-19
- Peptides
- Ectonucleotide pyrophosphatase/phosphodiesterase family member 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A